Trial Profile
The Safety of GSK Biological's H1N1 Pandemic Vaccine in Manitoba, Canada
Status:
Active, no longer recruiting
Phase of Trial:
Phase IV
Latest Information Update: 30 Jun 2023
Price :
$35
*
At a glance
- Drugs Influenza A virus H1N1 vaccines (Primary)
- Indications Influenza A virus H1N1 subtype
- Focus Adverse reactions
- 26 Aug 2011 New trial record